The largest database of trusted experimental protocols
> Living Beings > Virus > Leukemia Virus, Feline

Leukemia Virus, Feline

Leukemia Virus, Feline: A retrovirus that causes leukemia and lymphoma in cats.
It belongs to the Gammaretrovirus genus and is closely related to the human T-cell leukemia virus.
Feline leukemia virus infection is a major health concern for domestic cats, leading to various hematologic disorders and immunodeficiency.
Understanding the biology and pathogenesis of this virus is crucial for developing effective preventive and therapeutic strategies.

Most cited protocols related to «Leukemia Virus, Feline»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 1998
Animals Eosin Felidae Formalin Infection Leukemia Virus, Feline Paraffin Embedding Physical Examination Tissues
Pseudotyped particles (pp) expressing envelope glycoproteins from different HCV strains (Supplementary Methods), VSV, MLV, influenza, measles and endogenous feline leukemia virus (RD114) and HCVcc were generated as described [14 (link),15 (link),21 (link),41 (link)–45 (link)]. Infection of Huh7, Huh7.5.1 cells and PHH with HCVpp, HCVcc (TCID50 103–104 mL−1 for Huh7.5.1 experiments, TCID50 105–106 mL−1 for PHH experiments) and serum-derived HCV (genotype 1b) [46 (link)] was performed as described [14 (link),19 (link),21 (link),47 (link)]. Polarization of HepG2-CD81, determination of TJ integrity and cell polarity index were performed, measured and calculated as previously described [15 (link)]. Gene silencing was performed 3 d prior to infection as described for the RNAi screen (Supplementary Methods). Inhibitors, antibodies or ligands were added 1 h prior to HCVpp or HCVcc infection and during infection unless otherwise stated. Experiments with RTK ligands were conducted with serum-starved cells. Unless otherwise stated, HCV entry and infection was assessed by luciferase reporter gene expression.
Publication 2011
Antibodies Cells Genes, Reporter Genotype Glycoproteins Infection Influenza inhibitors Leukemia Virus, Feline Ligands Luciferases Measles RNA Interference Serum Strains
All cats included in this study were in experimental studies officially approved by the Veterinary Office of the Swiss Canton of Zurich (TVB 30/2003, 59/2005, and 99/2007). The cats were kept in groups under optimal ethological conditions in a barrier facility, as previously described [21 (link)]. All cats were euthanized for reasons unrelated to the present study.
Tissue samples were collected upon necropsy from two feline leukemia virus-infected cats (cat B8, female 3.8 years old, and cat 15, neutered male, 1.3 years old). The cats underwent histopathological examination, and samples from the rectum, colon, spleen, and jejunum were collected. Tissues for histology were processed as described [22 ], histologically examined, and verified to be free of pathological abnormalities. The samples for molecular analysis were snap frozen in liquid nitrogen following collection and stored at −80°C until nucleic acid extraction.
Full text: Click here
Publication 2013
Autopsy Colon Congenital Abnormality Felis catus Freezing Jejunum Leukemia Virus, Feline Males Nitrogen Nucleic Acids Rectum Spleen Tissues Woman
To make constructs for production of C-terminally His6-tagged INs, DNA fragments encoding HIV-2, MVV, BIV, EIAV, MPMV, FeLV, HTLV-1 and PFV INs were PCR-amplified using Pfu DNA polymerase (Stratagene) and the primer pairs PC155/PC156, PC123/PC122, PC127/PC126, PC125/PC124, PC161/PC160, PC187x/PC186, PC175/PC176 and PC146/PC145, respectively. Resulting amplicons digested with SalI were ligated between NdeI and SalI sites of pET20-b(+) (Novagen) (NdeI site of the vector was filled-in using Pfu polymerase to allow blunt-end ligation). The plasmid pKB-IN6H used for bacterial expression of HIV-1 IN with a C-terminal His6-tag has been described (25 (link)).
To make pCPH6P-BIV-IN, for production of BIV IN with N-terminal His6-tag and a human rhinovirus (HRV) 3C protease cleavage site, a PCR fragment obtained using primers PC143 and PC144 and re-amplified using primers PC142 and PC144, was digested with XhoI and ligated between NdeI and XhoI sites of pET15b (Novagen) (NdeI site of the vector was filled-in to allow blunt-end ligation). To make pCPH6P-EIAV-IN for expression of EIAV IN with a removable His6-tag, a PCR amplicon obtained with primers PC173 and PC174 was digested with XmaI and BamHI and subcloned into pCPH6P-BIV-IN, to replace the BIV IN CDS. The plasmids pRP1012, pCP-Nat75 and pCP-Nat75(D366N) were used for bacterial expression of HIV-1 IN with an N-terminal His6-tag and a thrombin cleavage site, non-tagged human LEDGF and LEDGF(D366N), respectively (25 (link),31 (link),51 (link)).
Publication 2006
3C protease, Rhinovirus Bacteria Cloning Vectors Cytokinesis his6 tag HIV-1 HIV-2 Homo sapiens Human T-lymphotropic virus 1 Infectious Anemia Virus, Equine lens epithelium-derived growth factor Leukemia Virus, Feline Ligation Oligonucleotide Primers Pfu DNA polymerase Plasmids Thrombin
Diagnostic testing undertaken included p27 testing with three different point-of-care (PoC) FeLV antigen kits, p27 testing with a laboratory-based non-proprietary ELISA (in use since before PoC FeLV testing became available), semi-quantitative real-time proviral PCR (qPCR) testing to detect FeLV proviral DNA in leukocytes, semi-quantitative qRT-PCR testing to detect FeLV RNA in plasma, and testing for anti-FeLV neutralising antibodies (NAb). The same panel of FeLV tests was performed for all cats, on the same blood samples collected at a single time point, as outlined below. Occasionally, insufficient sample volume precluded all tests from being performed.
Whole blood samples were collected into two EDTA tubes from each cat and transported on ice to the UoS within 6 hours of collection. One tube was centrifuged for 3 min at 12,000× g and harvested plasma was aliquoted into two plain tubes using a sterile pipette and stored at −80 °C. At the end of the sampling period, one aliquot of frozen plasma from each cat was transported on dry ice to the University of Zurich for qRT-PCR testing and laboratory-based p27 ELISA testing, while the other aliquot of frozen plasma was thawed and transported on ice to the University of Glasgow for NAb testing. PoC testing with three FeLV kits (used concurrently) was performed with whole blood samples at the UoS, within 24 h of blood collection using the second EDTA tube, and DNA extraction from leukocytes was performed using sample collected in the same EDTA tube within 72 h of collection and stored at −80 °C for batch qPCR testing at the UoS.
Results from these analyses enabled classification of cats as FeLV-uninfected or FeLV-infected, using the following definitions (Table 1). FeLV-uninfected cats included FeLV-unexposed cats (p27-negative, qPCR-negative, NAb-negative) and FeLV-abortive infections (p27-negative, qPCR-negative, NAb-positive). FeLV-infected cats included cats with a ‘presumptively regressive infection’ (p27-negative, qPCR-positive, NAb negative or positive) and cats with a ‘presumptively progressive infection’ (p27-positive, qPCR-positive, NAb negative or positive). FeLV-vaccinated cats uncommonly produce NAb following vaccination without exposure [26 (link),27 (link),28 (link)], and instead, FeLV vaccination is thought to ‘prime’ the immune system and boost the NAb response following exposure [7 (link)]. Consequently, FeLV-vaccinated/FeLV-uninfected cats that tested NAb-positive were considered FeLV-vaccinated cats that had come into contact with the virus and were classified as ‘presumptively abortive infections’ (versus FeLV-unvaccinated/FeLV-uninfected cats that tested NAb-positive and were considered as ‘definitively abortive infections’). ‘Presumptively’ regressive and progressive infections were described because, in the absence of repeated testing, a transient viraemia may have been present in some cats, resulting in some regressive infections being incorrectly classified as progressive infections [1 (link),2 (link),29 (link)]. Detection of vRNA by qRT-PCR testing was not included in the definition for progressive infections, as has been suggested elsewhere, since residual plasma was not available from all FeLV-infected cats for testing [17 (link),29 (link)].
Full text: Click here
Publication 2019
Anti-Antibodies Antibodies Antibody Formation Antigens Blood Dry Ice Edetic Acid Enzyme-Linked Immunosorbent Assay Felidae Freezing Infection Leukemia Virus, Feline Leukocytes Plasma Proviruses Real-Time Polymerase Chain Reaction Sterility, Reproductive System, Immune Transients Vaccination Viremia Virus

Most recents protocols related to «Leukemia Virus, Feline»

Thirteen serologically FeLV-positive cats were determined to have WW, and 9 FeLV-negative cats were determined to have normal whiskers. The samples were attached to a glass slide with clear tape, and the hair morphology was observed under a light microscope.
Full text: Click here
Publication 2023
Felidae Hair Leukemia Virus, Feline Light Microscopy Vibrissae
Of 358 cats, 223 cases had recorded information available for the following examined items: signs of lethargy and anorexia, the presence of WW, body weight, sex, and age. Furthermore, packed cell volume (PCV), white blood cell (WBC) count, total protein (TP), glucose (Glu), alanine aminotransferase (ALT), and blood urea nitrogen (BUN) were detected by normal blood tests. Viral infection was determined using a rapid test kit (SNAP FIV/FeLV Combo Test, IDEXX Japan, Tokyo), which detects the viral antigen (FeLV p27, core protein of the virus) and anti-FIV-specific antibody.
Full text: Click here
Publication 2023
Anorexia Antibodies, Anti-Idiotypic Antigens, Viral Body Weight D-Alanine Transaminase Felidae feline leukemia virus protein p27 Glucose Hematologic Tests Lethargy Leukemia Virus, Feline Leukocyte Count Proteins Urea Nitrogen, Blood Viral Core Proteins Virus Diseases
The upper lip tissues (proboscis) including the whisker follicles from 36 cases were formalin fixed, embedded in paraffin wax, and stained with hematoxylin and eosin (HE). Samples were collected humanly from cadavers with the owners’ consent and permission. IHC detection of FeLV antigens (p27, gp70 and p15E) was also performed. The primary antibodies used were the following mouse monoclonal antibodies: FeLV p27 (clone PF12J-10A, Abcam, Cambridge, England), gp70 (clone C11D8, Novus Biologicals, CO, USA), and p15E (clone PF6J-2A1, Novus Biologicals). Briefly, for antigen activation, each microsliced specimen was immersed in 0.01 M citrate buffer (pH 5.4) and microwaved at 98 °C for 15 min. Endogenous peroxidase activity was inhibited by performing the reaction in 3% hydrogen peroxide-containing methanol solution for 15 min at room temperature. To inhibit nonspecific reactions, slides were treated with Blocking One Histo reagent (Nacalai Tesque, Kyoto, Japan) and normal goat serum. All primary antibodies were used at a 300-fold dilution and reacted at 4 °C overnight. Phosphate buffer saline (PBS) was used as a negative control. After the primary antibody reaction, the slides were washed with PBS and incubated with peroxidase-conjugated goat anti-mouse antibody (Nichirei Bioscience, Tokyo) for 30 min at room temperature. Each antigen–antibody reaction was colorized with 3, 3'-diaminobenzidine and counterstained (nuclear staining) with hematoxylin.
Full text: Click here
Publication 2023
Antibodies Antibodies, Anti-Idiotypic Antigen-Antibody Reactions Antigens Biological Factors Buffers Cadaver Citrates Clone Cells Eosin feline leukemia virus protein p27 Formalin Goat Hair Follicle Hematoxylin Immunoglobulins Leukemia Virus, Feline Methanol Monoclonal Antibodies Mus Novus Paraffin Peroxidase Peroxides Phosphates Saline Solution Serum Technique, Dilution Tissues Tritium Vibrissae
First, the associations between the presence or absence of WW and serological FeLV or FIV infection were determined by using the chi-square test [25 (link)]. Next, multivariate analysis (logistic analysis) [26 (link)] was performed to test the association between “serological FeLV detection” and the above clinical examination items. The sensitivity, specificity, positive predictive value and likelihood ratio were calculated between FeLV serology and WW positivity according to a previous report [11 (link)].
Full text: Click here
Publication 2023
Hypersensitivity Infection Leukemia Virus, Feline Physical Examination
To identify diseases present in cats with wavy whiskers (WW) on their faces, we recorded information from examinations of cats visiting Niihama Animal Hospital in Ehime Prefecture, Japan, during 2006–2013. A Significant wavy change was defined as more than two regions with bends in one whisker, and a cat possessing more than two whiskers with wavy changes was determined to be a WW-positive cat (Fig. 1A) with the agreement of 3 clinicians (MM, YM, and IH). To accumulate enough WW-positive cats, WW-negative cats were also randomly recorded. A total of 358 cats, including 56 with WW, were enrolled in the present study. Some of the available case information about clinical diagnosis, especially FeLV-related disease or not, was recorded.
Full text: Click here
Publication 2023
Decompression Sickness Diagnosis Face Felis catus Leukemia Virus, Feline Physical Examination Vibrissae

Top products related to «Leukemia Virus, Feline»

Sourced in United States
The SNAP FIV/FeLV Combo Test is a rapid in-clinic diagnostic test used to detect the presence of antibodies to Feline Immunodeficiency Virus (FIV) and the Feline Leukemia Virus (FeLV) antigen in cats. The test provides qualitative results, indicating whether the animal is positive or negative for these viral infections.
Sourced in United States, Brazil
The SNAP Feline Triple Test is a veterinary diagnostic tool designed to detect the presence of three common feline infectious agents: Feline Leukemia Virus (FeLV), Feline Immunodeficiency Virus (FIV), and Heartworm Antigen. The test provides a quick and convenient way to screen for these conditions in cats.
Sourced in United States
The SNAP Combo Plus FeLV antigen and FIV antibody test is a rapid in-clinic test kit that detects the presence of feline leukemia virus (FeLV) antigen and feline immunodeficiency virus (FIV) antibodies in cat blood samples. The test provides qualitative results indicating whether the sample is positive or negative for these feline viral infections.
Sourced in United States
The SNAP FIV/FeLV Combo is an in-clinic diagnostic test used to detect the presence of antibodies to Feline Immunodeficiency Virus (FIV) and the presence of Feline Leukemia Virus (FeLV) antigen in feline blood samples. The test provides qualitative results to aid in the diagnosis of feline retroviral infections.
Sourced in Sweden, United States, United Kingdom, Germany, Canada, Japan, Italy, China, France, Australia, Belgium, Austria, Spain, Switzerland, Norway, New Zealand, Denmark, Finland, Georgia
Ficoll-Paque PLUS is a sterile, ready-to-use medium for the isolation of mononuclear cells from blood or bone marrow by density gradient centrifugation. It is a polysucrose and sodium diatrizoate solution with a density of 1.077 g/mL.
Sourced in United States
The SNAP Combo Plus FeLV ag/FIV ab test is a diagnostic tool designed to detect the presence of feline leukemia virus antigen and feline immunodeficiency virus antibodies in cats. It provides a simple and efficient method for veterinary professionals to screen for these common feline diseases.
Sourced in China, United States, Germany
2 × Taq Master Mix is a ready-to-use solution that contains all the necessary components for PCR amplification, including Taq DNA polymerase, dNTPs, and buffers. It is designed to simplify the PCR setup process and improve consistency in results.
Sourced in United States
Witness FeLV-FIV is a laboratory diagnostic test kit designed to detect the presence of feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) antigens in cat samples. The test provides rapid, qualitative results and is intended for use by veterinary healthcare professionals.
Sourced in United States
The SNAP® FIV Antibody/FeLV Antigen Combo Test is a rapid in-clinic diagnostic test that detects the presence of antibodies to Feline Immunodeficiency Virus (FIV) and the presence of Feline Leukemia Virus (FeLV) antigen in cat blood samples.
Sourced in United States
The Pet Check FIV antibody test kit is a diagnostic tool designed to detect the presence of antibodies to the Feline Immunodeficiency Virus (FIV) in cats. The test kit utilizes an immunochromatographic method to provide a rapid, qualitative result.

More about "Leukemia Virus, Feline"

Feline Leukemia Virus (FeLV) is a retrovirus that belongs to the Gammaretrovirus genus and is closely related to the human T-cell leukemia virus.
It is a major health concern for domestic cats, leading to various hematologic disorders and immunodeficiency.
FeLV infection can cause leukemia and lymphoma in cats.
Understanding the biology and pathogenesis of FeLV is crucial for developing effective preventive and therapeutic strategies.
The SNAP FIV/FeLV Combo Test, SNAP Feline Triple Test, and SNAP Combo Plus FeLV antigen and FIV antibody test are commonly used diagnostic tools to detect FeLV and Feline Immunodeficiency Virus (FIV) infections.
Ficoll-Paque PLUS is a reagent used in the separation and purification of mononuclear cells, which can be useful in FeLV research.
The SNAP Combo Plus FeLV ag/FIV ab test, 2 × Taq Master Mix, and Witness FeLV-FIV are additional products that may be utilized in FeLV-related studies.
The SNAP® FIV Antibody/FeLV Antigen Combo Test and Pet Check FIV antibody test kit are also relevant for FeLV and FIV detection and research.
Leveraging the insights from these products and tools can help optimize the research process and lead to more effective preventive and therapeutic strategies for feline leukemia virus infection.
By combining this information with the understanding of FeLV biology and pathogenesis, researchers can take their studies to the next level.